Quick Answer
BioScience Health Innovations, Inc. reported Total Revenue of $5.69 million for fiscal year 2025.
BioScience Health Innovations, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $5.69M | +208.3% |
| 2024 | $1.84M | +208.7% |
| 2023 | $597.6K | +761.8% |
| 2022 | $69.3K | — |
| 2022 | $0.00 | — |
| 2021 | $0.00 | — |
| 2020 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.13M | +97.5% | -35.6% |
| June 30, 2025 | $1.76M | +357.5% | +43.2% |
| March 31, 2025 | $1.23M | +342.0% | +114.2% |
| September 30, 2024 | $573.0K | +198.2% | +49.1% |
| June 30, 2024 | $384.2K | +453.0% | +38.4% |
| March 31, 2024 | $277.6K | +758.5% | +44.5% |
| September 30, 2023 | $192.2K | +874.1% | +176.6% |
| June 30, 2023 | $69.5K | — | +114.8% |
- BioScience Health Innovations, Inc. showed an increase of +208.3% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from BioScience Health Innovations, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: